The adjustment in price target by Barclays reflects a minor negative sentiment towards Ameren's stock, suggesting a slight bearish outlook. However, maintaining an Equal-Weight rating indicates that the analyst sees the company's stock as fairly valued at its current price, balancing out the potential short-term impact. The change is modest, hence the neutral score, but it's directly relevant and important for investors tracking analyst ratings and price targets.